-+ 0.00%
-+ 0.00%
-+ 0.00%

Bioretec Q3 net loss narrows to EUR 1.84 million; Q3 revenue jumps 86% to EUR 1.33 million

PUBT·11/12/2026 06:34:19
Listen to the news
Bioretec Q3 net loss narrows to EUR 1.84 million; Q3 revenue jumps 86% to EUR 1.33 million
  • Bioretec’s third-quarter 2026 net loss narrowed year-over-year to EUR 1.84 million.
  • Revenue rose 86% year-over-year to EUR 1.33 million, while US revenue more than doubled to EUR 443,000.
  • September FDA clearance enabled US commercialization of the ActivaScrew Cannulated COM biodegradable compression screw for its approved indication.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioretec Oyj published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.